Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | +0.61% | +3.11% | -30.54% |
May. 15 | JPMorgan Downgrades Rallybio to Neutral From Overweight | MT |
May. 09 | Rallybio Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.54% | 67.98M | |
+47.93% | 56.87B | |
+37.15% | 39.72B | |
-6.04% | 39.27B | |
-6.90% | 28.73B | |
+12.92% | 26.21B | |
-16.75% | 19.79B | |
+31.19% | 12.28B | |
+28.00% | 12.23B | |
+0.03% | 12.12B |
- Stock Market
- Equities
- RLYB Stock
- News Rallybio Corporation
- Transcript : Rallybio Corporation Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 03